Afya Limited (NASDAQ:AFYA – Get Free Report) VP Lelio De Souza Junior sold 36,204 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $15.00, for a total transaction of $543,060.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
Lelio De Souza Junior also recently made the following trade(s):
- On Friday, June 26th, Lelio De Souza Junior sold 41,541 shares of Afya stock. The stock was sold at an average price of $15.00, for a total transaction of $623,115.00.
- On Thursday, April 9th, Lelio De Souza Junior sold 16,279 shares of Afya stock. The shares were sold at an average price of $14.53, for a total transaction of $236,533.87.
- On Tuesday, April 7th, Lelio De Souza Junior sold 26,753 shares of Afya stock. The stock was sold at an average price of $14.95, for a total transaction of $399,957.35.
Afya Trading Down 2.6%
NASDAQ:AFYA traded down $0.40 on Monday, reaching $14.87. The company’s stock had a trading volume of 172,657 shares, compared to its average volume of 107,339. Afya Limited has a 12-month low of $13.00 and a 12-month high of $17.48. The stock has a 50 day moving average price of $14.28 and a 200 day moving average price of $14.54. The firm has a market cap of $1.39 billion, a price-to-earnings ratio of 9.72, a price-to-earnings-growth ratio of 1.57 and a beta of 0.32. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.42.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
A number of equities research analysts have commented on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a report on Monday, April 20th. Bank of America reiterated a “neutral” rating on shares of Afya in a research report on Thursday, June 11th. Zacks Research downgraded Afya from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 6th. JPMorgan Chase & Co. dropped their price objective on Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a research report on Monday, June 22nd. Finally, Wall Street Zen cut shares of Afya from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 2nd. One analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $17.10.
View Our Latest Stock Report on AFYA
About Afya
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
See Also
- Five stocks we like better than Afya
- Flash Crash or Cash? The AI Hardware Reset Investors Can’t Ignore
- As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner
- KBR Insiders Are Buying While the Market Misreads Its Spinoff
- Contrarian Alert: 5 Downgraded Stocks That May Reward Long-Term Investors
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
